BBO-10203 — Clinical data readout
Q4 2026
BBO-11818 and BBO-10203 monotherapy data update in the fourth quarter of 2026.Source filing
BBOT biotech catalysts & pipeline
BRIDGEBIO ONCOLOGY THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
BBO-11818 — Clinical data readout
Q4 2026
BBO-11818 and BBO-10203 monotherapy data update in the fourth quarter of 2026.Source filing
BBO-10203 — Clinical data readout
mid-2027
Data from BBO-11818 and BBO-10203 internal and standard-of-care combination cohorts in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) expected in mid-2027.Source filing
BBO-11818 — Clinical data readout
mid-2027
Data from BBO-11818 and BBO-10203 internal and standard-of-care combination cohorts in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) expected in mid-2027.Source filing
BBO-8520 — Clinical data readout
mid-2027
Expanded BBO-8520 plus pembrolizumab dataset in 2L+ KRAS G12C inhibitor-experienced NSCLC expected in mid-2027.Source filing